CClinicalTrials.gg
CompletedNCT04461093Updated May 1, 2024

Comparison of the Efficacy of Acupressure P6 Point, Dexamethasone and Ondansetron Versus Palonosetron Monotherapy for Preventing Postoperative Nausea and Vomiting in Laparoscopic Surgery

An interventional study of Acupressure wristband and Palanosetron in Palonosetron, sponsored by Mohd Zulfakar Mazlan, MBBS. Completed at 2 sites in Malaysia. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-01.

Sponsored by Mohd Zulfakar Mazlan, MBBS · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Postoperative nausea and vomiting (PONV) is defined as nausea and/or vomiting occurring within 24 hours after surgery, it commonly affects 20-30% patients but as high as 70-80% patients who are deemed high risk for PONV may be affected. PONV may cause unpleasant complications such as dehydration, electrolyte imbalance, suture dehiscence, aspiration of gastric contents, delayed recovery and prolonged hospital stay. Standard guideline recommended combination of anti-emetics to prevent PONV in high risk patients. The commonly used agents are dexamethasone and ondansetron which are cheaper although they are proven to be less effective as single agent when compared with newer agent such as palonosetron. As an adjunct or alternative to pharmacological treatment, acupressure P6 point has gained increasing attention for its possible value in preventing PONV. It is proven that acupressure reduced the incidences of PONV when combined with pharmacological treatment. It is postulated that acupressure active Aβ and Aδ fibres and stimulate the release of β-endorphine from hypothalamus. In addition, it is believed that acupressure might act on dopaminergic, serotonergic and norepinerphrinergic fibres which might has a role in PONV prevention.

Read the detailed description

This study is designed to compare the efficacy of palonosetron monotherapy versus combination of acupressure P6 point with dexamethasone and ondansetron in preventing PONV. It has been proven that palonosetron is more superior as single agent when compared with acupressure, dexamethasone and ondansetron separately. However, this might not be cost effective as palonosetron is more expensive than the other agents. In addition, the combination therapy has been reported better in preventing PONV when compared with monotherapy. The investigators need to investigate whether the combination of acupressure with dexamethasone and ondansetron exert an effect equal or even better than palonosetron monotherapy. The investigators hypothesis is the combination of acupressure P6 point with dexamethasone and ondansetron provide better prophylaxis againts PONV when compared with palonosetron. The requirement for rescue anti-emetics for combination of acupressure P6 point with dexamethasone and ondansetron group is lesser than palonosetron.

02

Conditions studied

03

In context

Vomiting

1,100 studies on the registry are indexed under Vomiting; 134 are open to participants now.

This study's enrollment of 90 is below the median of 107 across 935 interventional studies indexed under Vomiting.

Browse Vomiting studies →

Lead sponsor

Mohd Zulfakar Mazlan, MBBS is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. ASA I or II female patients aged 18 - 65 years old in view female patients are at higher risk of postoperative nausea and vomiting.
  2. Patients undergoing laparoscopic surgery.
  3. High risk for PONV (APFEL score 3-4).

Exclusion criteria

Exclusion Criteria:

  1. Patients with known allergic to dexamethasone, ondansetron and wristband.
  2. Patients who take anti-emetic, emetogenic drugs and glucocorticoids within 24 hours before surgery.
  3. Patients with upper limb disability which affect the application of wristband.
  4. Obese patients with BMI > 35 in view acupressure P6 wristband might be too tight to fit patient's wrist which might affect the correct placement of pressure point.
  5. Pre-existing vertigo
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Group I

    Group I (n=45) 1. Acupressure wristband 2. IV Dexamethasone 8mg 3. IV Ondansetron 4mg

    Other: Acupressure wristband and Palanosetron

  • Active comparator
    Group II

    Group II (n=45) 1. IV Palonosetron 0.075mg

    Other: Acupressure wristband and Palanosetron

Interventions

  • OtherAcupressure wristband and Palanosetron

    Group 1 Patients with odd numbers labelled form will be Group I patients. They will receive intravenous dexamethasone 8mg during induction. Acupressure P6 wristband is applied after induction and removed prior to emergence to maintain blinding. Intravenous ondansetron 4mg is given prior to skin closure. Group 11 Patients with even numbers labelled form will be Group II patients who will receive intravenous palonosetron 0.075mg during induction.

06

What researchers measure

Primary outcomes

  1. The incidence of postoperative nausea and vomiting immediately, at

    Time frame: Hours 6, postoperative.

  2. The incidence of postoperative nausea and vomiting immediately, at

    Time frame: Hours 12, postoperative

  3. The incidence of postoperative nausea and vomiting immediately, at

    Time frame: Hours 24, postoperative

  4. The incidence of postoperative nausea and vomiting immediately, at

    Time frame: Hours 48, postoperative

Secondary outcomes

  1. The proportion of patients require rescue anti-emetics immediately,

    Time frame: at Hours 6, postoperative.

  2. The proportion of patients require rescue anti-emetics immediately,

    Time frame: Hours 12, postoperative.

  3. The proportion of patients require rescue anti-emetics immediately,

    Time frame: Hours 24, postoperative.

  4. The proportion of patients require rescue anti-emetics immediately,

    Time frame: Hours 48, postoperative.

07

Study locations

2 sites
  • Mohd Zulfakar Mazlan, MBBS
    Kota Bharu, Kelantan 16150, Malaysia
  • Mohd Zulfakar Mazlan
    Kota Bharu, Kelantan 16150, Malaysia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04461093
Lead sponsor
Mohd Zulfakar Mazlan, MBBS
Responsible party
Mohd Zulfakar Mazlan, MBBS (Comparison of the efficacy of acupressure P6 point, dexamethasone and ondansetron versus palonosetron monotherapy for preventing postoperative nausea and vomiting in laparoscopic surgery, Universiti Sains Malaysia) — Sponsor-investigator
First posted
Jul 8, 2020
Start date
Jul 6, 2020
Primary completion
Nov 1, 2021
Completion
Nov 1, 2021
Last update
May 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion